Aug. 1 at 2:44 AM
$FTLF impressive turnaround by the CEO, thus far. I like their plan but I'm skeptical that they can continue to buy companies at 3-6x EBITDA and benefit from the conglomerate effect indefinitely but I like that they aren't leveraged and their M&A seems super disciplined thus far. Muscle Pharm is a great name and at 18.5m they picked up 15 years of customer data and are already bringing in around 4 mill in profit a year from it. Smoking good deal. I like the idea of a supplement Warren buffett - make smart acquisitions and compound revenue internally. Their current price relative to cash flow gives them the option to buy back shares at an attractive price relative to intrinsic value if they can't find deals. Need to do more research on the other publicly traded leaders in the sports and health and wellness supplement industry.
